Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study
Paediatr Drugs. 2025 Oct 8. doi: 10.1007/s40272-025-00717-2. Online ahead of print. ABSTRACT BACKGROUND: Pediatric-onset inflammatory bowel diseases (IBD) are associated with an elevated risk of …